Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Liposomal Paclitaxel vs Paclitaxel in Solid Tumors
NCT00606515Phase 4Completed
- Sponsor
- Luye Pharma Group
- Start
- Feb 2008
- Primary completion
- Oct 2008
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal paclitaxel in solid tumor (2 arms), sponsored by Luye Pharma Group. Primary endpoint: Pharmacokinetic parameters at 72 hours. Started Feb 2008; status: completed.
02
Drugs
liposomal paclitaxel
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00606515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00606515.